PET/CT Identifies Pubic Melorheostosis with High 68Ga-PSMA Uptake in a Patient with Prostate Cancer
PDF
Cite
Share
Request
Interesting Image
E-PUB
28 April 2026

PET/CT Identifies Pubic Melorheostosis with High 68Ga-PSMA Uptake in a Patient with Prostate Cancer

Mol Imaging Radionucl Ther. Published online 28 April 2026.
1. King Hussein Cancer Center Clinic of Nuclear Medicine and Positron Emission Tomography and Computed Tomography, Amman, Jordan
No information available.
No information available
Received Date: 28.09.2025
Accepted Date: 21.04.2026
E-Pub Date: 28.04.2026
PDF
Cite
Share
Request

Abstract

Melorheostosis, a rare benign bone disorder marked by cortical thickening and irregular hyperostosis, typically affects peripheral bones but can also involve the axial skeleton. Though various molecular imaging radiotracers have been used to evaluate this condition, there are no previous reports of positive 68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography (68Ga-PSMA PET/CT) findings in melorheostosis. This case presents a 70-year-old man with metastatic prostate cancer whose 68Ga-PSMA PET/CT scan revealed intense 68Ga-PSMA uptake in pubic melorheostosis seen on magnetic resonance imaging. The case highlights the possibility of 68Ga-PSMA-avid melorheostosis and suggests 68Ga-PSMA PET/CT may have a role in the evaluation of melorheostosis.

Keywords:
Melorheostosis, 68Ga-PSMA, diagnostic challenge, PET/CT, prostate cancer, false positive

Ethics

Informed Consent: The patient provided written informed consent.

Authorship Contributions

Surgical and Medical Practices: D.A.S., A.S.A., A.A-I., Concept: D.A.S., A.S.A., A.A-I., Design: D.A.S., A.S.A., A.A-I., Data Collection or Processing: D.A.S., A.S.A., A.A-I., Literature Search: D.A.S., A.S.A., A.A-I., Writing: D.A.S., A.S.A., A.A-I.
Conflict of Interest: No conflicts of interest were declared by the authors.
Financial Disclosure: The authors declare that this study has received no financial support.

References

1
Kalbermatten NT, Vock P, Rüfenacht D, Anderson SE. Progressive melorheostosis in the peripheral and axial skeleton with associated vascular malformations: imaging findings over three decades. Skeletal Radiol. 2001;30:48-52.
2
Suresh S, Muthukumar T, Saifuddin A. Classical and unusual imaging appearances of melorheostosis. Clin Radiol. 2010;65:593-600.
3
de Galiza Barbosa F, Queiroz MA, Nunes RF, Costa LB, Zaniboni EC, Marin JFG, Cerri GG, Buchpiguel CA. Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings. Cancer Imaging. 2020;20:23.
4
Fick CN, Fratzl-Zelman N, Roschger P, Klaushofer K, Jha S, Marini JC, Bhattacharyya T. Melorheostosis: a clinical, pathologic, and radiologic case series. Am J Surg Pathol. 2019;43:1554-1159.
5
Yao V, Berkman CE, Choi JK, O’Keefe DS, Bacich DJ. Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid. Prostate. 2010;70:305-316.
6
Sachpekidis C, Bäumer P, Kopka K, Hadaschik BA, Hohenfellner M, Kopp-Schneider A, Haberkorn U, Dimitrakopoulou-Strauss A. 68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer. Eur J Nucl Med Mol Imaging. 2018;45:904-912.
7
Jain TK, Vohra M, Sharma BS, Dhal S, Sharma LM. PSMA avidity in the heterotropic ossification—an incidental finding on PSMA PET/CT. Clin Nucl Med. 2024;49:e118-e9.
8
Sasikumar A, Joy A, Nanabala R, Pillai MRA, T.A H. 68Ga-PSMA PET/CT false-positive tracer uptake in paget disease. Clin Nucl Med. 2016;41:e454-e5.